日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Scar-associated endothelial-stellate cellular crosstalk drives fibrosis resolution in MASH.

MASH中瘢痕相关的内皮-星状细胞相互作用驱动纤维化消退。

Li Kenneth, Kumar Vardhman, To Tran, González-Domínguez Álvaro, Huria Janvi, Yu Maylene, Cogliati Bruno, Yashaswini Chittampalli N, Miller Mark, Branch Andrea D, Giotti Bruno, Tsankov Alexander M, Chen Li, Petitjean Mathieu, Kirkpatrick Jesse D, Bhatia Sangeeta N, Friedman Scott L, Wang Shuang

Fat, fibrosis, and the future: navigating the maze of MASLD/MASH

脂肪、纤维化与未来:探索MASLD/MASH的迷宫

Friedman, Scott L

Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease

抗纤维化疗法治疗代谢功能障碍相关的脂肪肝疾病

Schwabe, Robert F; Tacke, Frank; Sugimoto, Atsushi; Friedman, Scott L

Resolvin D1-mediated cellular crosstalk protects against MASH.

Resolvin D1介导的细胞间通讯可防止MASH

Navarro-Corcuera Amaia, Zhu Yiwei, Ma Fanglin, Gupta Neha, Asplund Haley, Cogliati Bruno, Chipuk Jerry E, Rom Oren, Friedman Scott L, Sansbury Brian E, Huang Xin, Cai Bishuang

Depletion of tumor-reactive HSCs reveals their significance during different stages of liver metastasis

肿瘤反应性HSC的耗竭揭示了它们在肝转移不同阶段的重要性

Benedicto, Aitor; Herrero, Alba; Lopategi, Aritz; Friedman, Scott L; Boyano, Maria Dolores; Arteta, Beatriz

Mannose reduces fructose metabolism and reverses MASH in human liver slices and murine models in vivo.

甘露糖可降低果糖代谢,并逆转人肝切片和体内小鼠模型中的 MASH

Hong John G, Trotman Joshaya, Carbajal Yvette, Dey Poulomi, Glass Mariel, Sclar Victoria, Alter Isaac L, Zhang Peng, Wang Liheng, Chen Li, Petitjean Mathieu, Bhattacharya Dipankar, Wang Shuang, Friedman Scott L, DeRossi Charles, Chu Jaime

PDGFRß targeted positron emission tomography as a non-invasive biomarker for activated hepatic stellate cells: lasts steps before clinical translation.

PDGFRß靶向正电子发射断层扫描作为活化肝星状细胞的非侵入性生物标志物:临床转化前的最后步骤。

Yashaswini Chittampalli N, Mitran Bogdan, Papadopoulos Natalia, Wegrzyniak Olivia, Löfblom John, Nordström Helena, Velikyan Irina, Abouzayed Ayman, Johansson Lars, Hagmar Per, Wagner Michael, Frejd Fredrik Y, Korsgren Olle, Heldin Carl-Henrik, Friedman Scott L, Eriksson Olof

In vivo anti-FAP CAR T therapy reduces fibrosis and restores liver homeostasis in metabolic dysfunction-associated steatohepatitis

体内抗FAP CAR-T疗法可减少代谢功能障碍相关性脂肪性肝炎中的纤维化并恢复肝脏稳态

Yashaswini, Chittampalli N; Cogliati, Bruno; Qin, Tianyue; To, Tran; Williamson, Thomas; Papp, Tyler E; Li, Kenneth; Rasul, Raisa; Chen, Li; Lightstone, Adi; Aghajanian, Haig; Parhiz, Hamideh; Wang, Shuang; Rurik, Joel G; Epstein, Jonathan A; Friedman, Scott L

Cannabinoid Receptor 2 Activating Antibodies: A Promising Therapeutic Strategy for Macrophage-Driven Fibro-Inflammatory Diseases

大麻素受体2激活抗体:一种治疗巨噬细胞驱动的纤维炎症性疾病的有前景的治疗策略

Gopireddy, Raghavender Reddy; Bhattacharya, Dipankar; Sen, Swastik; Schwartz, Monica A; Friedman, Scott L; Yu, Richard C; Takeuchi, Toshi; Schwimmer, Lauren J

Aramchol improves hepatic fibrosis in metabolic dysfunction-associated steatohepatitis: Results of multimodality assessment using both conventional and digital pathology

阿莫西林可改善代谢功能障碍相关性脂肪性肝炎的肝纤维化:采用常规病理学和数字病理学多模式评估的结果

Ratziu, Vlad; Yilmaz, Yusuf; Lazas, Don; Friedman, Scott L; Lackner, Caroline; Behling, Cynthia; Cummings, Oscar W; Chen, Li; Petitjean, Mathieu; Gilgun-Sherki, Yossi; Gorfine, Tali; Kadosh, Shaul; Eyal, Eli; Sanyal, Arun J